about
Duffy-null-associated low neutrophil counts influence HIV-1 susceptibility in high-risk South African black womenThe Duffy-null state is associated with a survival advantage in leukopenic HIV-infected persons of African ancestryHIV-1 disease-influencing effects associated with ZNRD1, HCP5 and HLA-C alleles are attributable mainly to either HLA-A10 or HLA-B*57 allelesIs there a common genetic basis for autoimmune diseases?Influence of variations in CCL3L1 and CCR5 on tuberculosis in a northwestern Colombian populationGenetic basis of Sjögren's syndrome. How strong is the evidence?Mendelian randomization: potential use of genetics to enable causal inferences regarding HIV-associated biomarkers and outcomes.Reply to: "Experimental aspects of copy number variant assays at CCL3L1".Bcl-2 antagonist killer 1 (BAK1) polymorphisms influence the risk of developing autoimmune rheumatic diseases in women.TIRAP (MAL) S180L polymorphism is a common protective factor against developing tuberculosis and systemic lupus erythematosus.Interleukin-1beta polymorphisms in Colombian patients with autoimmune rheumatic diseases.The Multiple Autoimmune Syndromes. A Clue for the Autoimmune TautologyThe IκBL gene polymorphism influences risk of acquiring systemic lupus erythematosus and Sjögren’s syndromeThe Nature and Nurture of Common AutoimmunityThe kaleidoscope of autoimmunity: multiple autoimmune syndromes and familial autoimmunityFamilial clustering of autoimmune diseases in patients with type 1 diabetes mellitusAnalysis of IL1B, TAP1, TAP2 and IKBL polymorphisms on susceptibility to tuberculosisResponse: Association of Duffy Antigen Genotypes with HIV-AIDS Susceptibility
P50
Q24613572-A5939FA5-8F1D-4061-AE44-7FBE7B18B4DEQ24628840-A0C4D5C6-3E6F-4974-B8E5-7869E35C37CDQ33382373-16D5920D-0A22-4F99-8E6C-DAFFFCAD1BA8Q34589958-352877C0-B391-4754-A3E7-7A32239256E9Q34988294-A12F123A-E216-4732-A5BA-15E92D8F5C99Q36502292-580D6A0B-B10C-43E4-8D69-BFC0C9681FD5Q37295610-032E3222-9A22-46FF-AF1E-8501FF3BB2F0Q43535171-657437BA-E6FC-4FA0-940C-397939DFC520Q51771654-1EE8E47D-B3EB-4DD6-95CD-3601CDA853B0Q54536891-3DB13F30-0B6D-4750-9E23-05F77DF50322Q54698543-7DD7F14F-F9A3-4B30-975F-3F723CD9CC42Q56452307-3841C03E-0039-48F1-AF9A-4AD526DEC29DQ56452735-67680EF7-75B1-4738-92CE-2C78F73D6482Q56452780-72891F1E-F780-42C6-A4FC-0FFBE2974A21Q56452789-70ABCF0F-6F37-467B-B827-D84DA8B4F9D1Q56452893-BD75DFC3-4601-45A7-9B17-9C416E4F9B1BQ56452913-D5F49CA7-619D-4C8D-ADCC-C2D5EF1B7BEEQ56853445-AB8E3A7F-F411-4795-BE89-FBDD88FC0431
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
John Castiblanco
@ast
John Castiblanco
@en
John Castiblanco
@es
John Castiblanco
@nl
type
label
John Castiblanco
@ast
John Castiblanco
@en
John Castiblanco
@es
John Castiblanco
@nl
prefLabel
John Castiblanco
@ast
John Castiblanco
@en
John Castiblanco
@es
John Castiblanco
@nl
P106
P1153
13605036200
P31
P496
0000-0003-2556-3697